ProShare Advisors LLC grew its position in shares of Atrion Co. (NASDAQ:ATRI – Get Rating) by 14.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,904 shares of the medical instruments supplier’s stock after acquiring an additional 1,842 shares during the quarter. ProShare […]
MetLife Investment Management LLC lowered its holdings in Atrion Co. (NASDAQ:ATRI – Get Rating) by 4.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 741 shares of the medical instruments supplier’s stock after selling 36 shares during the period. […]
ICW Investment Advisors LLC lessened its holdings in Atrion Co. (NASDAQ:ATRI – Get Rating) by 1.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,387 shares of the medical instruments supplier’s stock after selling 25 shares during the […]
ProShare Advisors LLC raised its holdings in shares of Atrion Co. (NASDAQ:ATRI – Get Rating) by 3.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,341 shares of the medical instruments supplier’s stock after purchasing an additional 424 shares during the quarter. […]
Atrion (NASDAQ:ATRI – Get Rating) and Integra LifeSciences (NASDAQ:IART – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership. Analyst Ratings This is a summary of recent ratings and price […]